U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07300813) titled 'Olistic_2025 for Hair Loss, Hair Growth, and Skin Improvement' on Dec. 04.
Brief Summary: The goal of this randomized, double-blind, placebo-controlled clinical trial is to find out whether daily oral intake of the nutraceutical Olistic Next Women can reduce hair loss, improve hair growth and quality, and improve signs of skin aging in women with early female-pattern hair loss. One hundred healthy women aged 50-65 years with initial FPHL will be randomly assigned 1:1 to receive either Olistic Next Women or a matching placebo for 6 months. Participants will drink one vial per day for 28 days, rest 2 days each month, and repeat this c...